Cargando…

Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort

OBJECTIVE: To explore the survival benefit of tofacitinib in addition to dexamethasone in hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia. PATIENTS AND METHODS: This is a single-center retrospective observational study. All patients who were hospitalized at De...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayek, Maroun E., Mansour, Michael, Ndetan, Harrison, Burkes, Quentin, Corkern, Robert, Dulli, Ammar, Hayek, Reya, Parvez, Karim, Singh, Satwinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998063/ https://www.ncbi.nlm.nih.gov/pubmed/33817559 http://dx.doi.org/10.1016/j.mayocpiqo.2021.03.007

Ejemplares similares

THE EFFICACY OF REMDESIVIR WITH DEXAMETHASONE VS. DEXAMETHASONE ALONE IN ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

Dexamethasone/prednisone/tofacitinib: COVID-19, thromboembolic episodes and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports
Publicado: (2022)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
por: Spicka, Ivan, et al.
Publicado: (2019)

Dexamethason
por: de Graaf, Linda, et al.
Publicado: (2020)

Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease
por: Lee, Na Kyung, et al.
Publicado: (2022)

Dexamethasone Does not Compensate for Local Anesthetic Cytotoxic Effects on Tenocytes: Morphine or Morphine Plus Dexamethasone May Be a Safe Alternative
por: Oeyen, Anne Lene, et al.
Publicado: (2021)

Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
por: Chatterjee, Arindam, et al.
Publicado: (2017)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

Dexamethasone and Dexamethasone Phosphate: Effect on DMPC Membrane Models
por: Cámara, Candelaria Ines, et al.
Publicado: (2023)

Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT
por: Alite, Fiori, et al.
Publicado: (2022)

Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis.
por: Carmichael, J., et al.
Publicado: (1994)

Evaluation of gabapentin and dexamethasone alone or in combination for pain control after adenotonsillectomy in children
por: Amin, Sabry Mohammad
Publicado: (2014)

Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
por: Mansour, Ahmad M.
Publicado: (2018)

The effect of combination treatment using palonosetron and dexamethasone for the prevention of postoperative nausea and vomiting versus dexamethasone alone in women receiving intravenous patient-controlled analgesia
por: Ryoo, Seung-hwa, et al.
Publicado: (2015)

Dexamethasone to the rescue
por: Moon, Chang
Publicado: (2020)

Dexamethasone for pulpitis
por: Emanuel, R.
Publicado: (2020)

Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma
por: Matsue, Kosei, et al.
Publicado: (2015)

Retraction: Evaluation of gabapentin and dexamethasone alone or in combination for pain control after adenotonsillectomy in children
Publicado: (2018)

Commentary: Dexamethasone and dilemma
por: Joshi, Shrinivas, et al.
Publicado: (2022)

Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?
por: Cidad-Betegón, María del Pino, et al.
Publicado: (2020)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results
por: Richardson, Paul G., et al.
Publicado: (2018)

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
por: Usmani, Saad Z., et al.
Publicado: (2023)

P895: DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (D-VD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) ALONE IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED ANALYSIS OF LEPUS
por: Fu, W., et al.
Publicado: (2022)

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL
por: Sonneveld, P, et al.
Publicado: (2022)

P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL
por: Dimopoulos, MA, et al.
Publicado: (2022)

Effect of combinations of dexamethasone-ondansetron and dexamethasone-ondansetron-aprepitant versus aprepitant alone for early postoperative nausea and vomiting after day care gynaecological laparoscopy: A randomised clinical trial
por: Thanuja, Ingilala L, et al.
Publicado: (2021)

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
por: Hjorth, Martin, et al.
Publicado: (2012)

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
por: Iida, Shinsuke, et al.
Publicado: (2018)

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment
por: Dimopoulos, M A, et al.
Publicado: (2017)

An Injectable Click-Crosslinked Hydrogel that Prolongs Dexamethasone Release from Dexamethasone-Loaded Microspheres
por: Heo, Ji Yeon, et al.
Publicado: (2019)

Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery
por: Dubashynskaya, Natallia V., et al.
Publicado: (2021)

Dexamethasone: Bone marrow necrosis following off label treatment with dexamethasone: case report
Publicado: (2022)

Dexamethasone for Inner Ear Therapy: Biocompatibility and Bio-Efficacy of Different Dexamethasone Formulations In Vitro
por: Gao, Ziwen, et al.
Publicado: (2021)

Oral pulsed high-dose dexamethasone therapy for rheumatic diseases: An alternative safe and effective scheme
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis
por: Hosseini, Kamran, et al.
Publicado: (2016)

Comparing the Effect of Ondansetron–dexamethasone and Metoclopramide–dexamethasone on Postoperative Nausea and Vomiting after Gynecological Laparoscopy: A Randomized Double-blind Clinical Trial
por: Barzanji, Arvin, et al.
Publicado: (2022)

DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
por: Reddy, M. Saikumar, et al.
Publicado: (1986)

Dexamethasone-induced withdrawal seizure
por: Mahar, Santwana, et al.
Publicado: (2015)

Dexamethasone in community-acquired pneumonia
por: Lee, Nelson, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_140tq56dhb0cou365o7ohhs7j3